Does TOCILIZUMAB Cause Therapy non-responder? 1,775 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,775 reports of Therapy non-responder have been filed in association with TOCILIZUMAB (Tocilizumab-anoh). This represents 1.8% of all adverse event reports for TOCILIZUMAB.
1,775
Reports of Therapy non-responder with TOCILIZUMAB
1.8%
of all TOCILIZUMAB reports
510
Deaths
1,090
Hospitalizations
How Dangerous Is Therapy non-responder From TOCILIZUMAB?
Of the 1,775 reports, 510 (28.7%) resulted in death, 1,090 (61.4%) required hospitalization, and 727 (41.0%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOCILIZUMAB. However, 1,775 reports have been filed with the FAERS database.
What Other Side Effects Does TOCILIZUMAB Cause?
Drug ineffective (32,342)
Rheumatoid arthritis (20,652)
Pain (18,384)
Off label use (18,256)
Arthralgia (15,536)
Joint swelling (14,831)
Fatigue (13,802)
Rash (12,327)
Drug intolerance (11,952)
Contraindicated product administered (11,547)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
HYDROXYCHLOROQUINE (1,699)
ABATACEPT (1,615)
Which TOCILIZUMAB Alternatives Have Lower Therapy non-responder Risk?
TOCILIZUMAB vs TOCILIZUMAB-AAZG
TOCILIZUMAB vs TOCOPHEROL
TOCILIZUMAB vs TOFACITINIB
TOCILIZUMAB vs TOFERSEN
TOCILIZUMAB vs TOLNAFTATE